Virgil whitehurst, Ph.D

Virgil Whitehurst, PhD

Dr. Whitehurst's career as a Pharmacologist / Toxicologist at the Food and Drug Administration (FDA) spans 37 years. While at the FDA, Dr. Whitehurst provided critical review, interpretation, evaluation, and recommendation for numerous INDs and NDAs. He has conducted nonclinical and pharmacology studies in pulmonary and cardiovascular areas as well as other scientific studies in dental, dietary, and smoking cessation as part of a multidisciplinary research team for 25 years. In addition, he has served as an expert witness before FDA Advisory Committees, Commission, and Directorate. Prior to joining the FDA, Dr. Whitehurst was an Associate Professor of Biochemistry at both Howard University's Medical and Dental School. As a researcher, he designed and conducted studies in microbiology, pharmacology, toxicology, and biochemistry. He also designed, performed, analyzed scientific data, and appeared as an expert witness on behalf of various pharmaceutical companies. Dr. Whitehurst holds a BA in Chemistry from Anderson University, an MA in Education from Butler University, and a PhD in Pharmacology/Toxicology from Indiana University at Bloomington. He has published 35 scientific articles/abstracts on pulmonary and cardiovascular drug products. Dr. Whitehurst is a subject-matter expert in reproductive, immunologic, neurologic, pulmonary and cardiovascular toxicology as well as with carcinogenicity assessment. Dr. Whitehurst has expertise to critically review, evaluate, and interpret current scientific literature, research data and investigative reports, medical findings, and proposed or existing standards criteria. His expertise and extensive experience also enable evaluation of exposure and adverse chronic and acute health effects resulting from consumer products.